Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sino Biopharmaceutical Ltd.

www.sino-biopharm.com

Latest From Sino Biopharmaceutical Ltd.

Deal Watch: Novo Nordisk, Fauna To Explore Hibernation To Treat Obesity

A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.

Deals Business Strategies

Finance Watch: Cell And Gene Therapies Buck 2019’s Venture Capital Trend

Private Company Edition: VC deals are surging this year for cell and gene therapy firms, according to ARM’s third quarter report. Also, Vivo Capital and the CF Foundation plan to invest nearly $2bn in health care and life science opportunities, and Akeso completes $150m series D.

Financing Regenerative Medicine

Chi-Med Roll Continues With Positive Fruquintinib Phase III Data

Chi-Med's China-focused strategy is paying off with positive Phase III top-line results for its home-grown VEGF inhibitor fruquintinib, keeping it on track to for a filing this year. But competition looms.

Clinical Trials Research & Development

Multinationals Look To M&A As Key China Growth Driver

Mergers and acquisitions have been highlighted as key drivers of growth for pharma companies in China as domestic companies look to expand globally and multinationals attempt to localize.

BioPharmaceutical Medical Device
See All

Company Information

UsernamePublicRestriction

Register